Fintiv Rule Challenges Face Long Odds After Fed. Circ. Ruling

By Ryan Davis (March 16, 2021, 9:20 PM EDT) -- A Federal Circuit ruling from last week suggests critics of the Patent Trial and Appeal Board's policy of refusing to review patents when a trial is looming in district court face major obstacles in getting the courts to overturn the rule, and may need to hope the patent office or Congress steps in.

Technology companies and generic-drug makers have said the policy, known as the NHK-Fintiv rule after the PTAB rulings that established it, unfairly restricts the ability to seek inter partes review of patents under the America Invents Act. But in a decision Friday, the Federal Circuit all but ruled out...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!